What is Active Pharmaceutical Ingredients:
Active Pharmaceutical Ingredient or API is the chief therapeutic entity in a drug product. Simply put, that part of the drug product, which is responsible for its curative action is API. If a consider an example – in a Crocin brand tablet, Paracetamol 500 mg is actually the API (the powder which is responsible for the tablet’s power to cure fever). But actually, the tablet contains a lot more than just 500 mg of paracetamol. They may be some colorants, binders, fillers, preservatives, etc. as well in the tablet, apart from paracetamol. All these materials together are termed’Excipients’. So API (paracetamol) in combination with excipients (binders, fillers, colorants, etc.) constitutes any finished drug product (tablets, capsules, syrups, etc.)
Active Pharmaceutical Ingredients
| Sr. no. | Therapeutic Category | Product | Pharmacopoeia | Documentation | Status |
| 1 | NSAID & Pain management | Meloxicam | IP/ BP/ USP/ EP | DMF available | Commercial |
| Lornoxicam | INH | EDMF, CHINESE DMF, RUSSIAN DMF, ODMF | Commercial | ||
| Tenoxicam | BP/ USP | Tech pack | Commercial | ||
| Piroxicam | BP/ USP | Tech pack | Commercial | ||
| Piroxicam-β-Cyclodextrin complex | INH | Tech pack | Commercial | ||
| Pregabalin | IP/ INH/ BP/ USP | Tech pack | Commercial | ||
| Etoricoxib | INH/ IP | Tech pack | Commercial | ||
| 2 | Respiratory | Bromhexine HCl | IP/ BP/ EP | Tech pack | |
| Salmeterol Xinafoate | EP | Tech pack | |||
| Ambroxol HCl | BP/ USP | – | Under Development | ||
| 3 | Anti-Psychotic | Amisulpride | IP/ INH | Tech pack | Commercial |
| Levosulpiride | INH | Tech pack | Commercial | ||
| 4 | Anti-Allergic | Fexofenadine | USP | Tech pack | Commercial |
| Betahistine | BP/ EP/ USP | – | Under Development | ||
| 5 | Anti-Diabetic | Canagliflozin | INH | Tech pack | Commercial |
| Linagliptin | INH | DMF available | Commercial | ||
| Dapagliflozin | INH | – | Under Development | ||
| Empagliflozin | INH | – | Under Development | ||
| Sitagliptin | INH/ USP | – | Under Development | ||
| 6 | Anti-Ulcerative | Sucralfate | USP | DMF available | Commercial |
| 7 | Ophthalmic | Olopatadine HCl | IP/ USP | – | Under Development |
| 8 | Excipient | Ethyl Oleate – IP/BP/USP | IP/ BP/ USP | Tech pack | Commercial |
| Chlorobutanol Hemihydrate | EP/ BP/ USP | – | Under Development | ||
| 9 | Nutrition | Butaphosphan | INH | Tech pack | Commercial |
| Iron Sucrose | INH | – | Under Development | ||
| 10 | Anti-Infective | Nitroxinil – BP | BP | – | Under Development |
| Nitazoxanide INH/USP | INH/ USP | – | Under Development | ||
| Oxyclozanide – BP | BP | – | Under Development |
Note: All transactions are carried out in conformity with patent laws applicable in the buyer’s country. Responsibility with respect to third-party patent rights in a specific country lies exclusively with the buyer.